Summary Doubts have frequently been expressed about the effectiveness of the screening programme for cervical cancer in Britain. These doubts have been reinforced as a result of recent increases in mortality from this disease among younger women. In this paper we discuss trends in registration and mortality data, relate these to the level of screening, and conclude that screening may in fact have had a considerable impact on mortality rates. There is good evidence that in some age groups there has been a large increase in the incidence of carcinoma in situ of the cervix; it seems likely that the potential increase in cervical cancer incidence and mortality may have been partially prevented as a result of the screening programme. The extent of this effect cannot be quantified precisely because of uncertainties concerning the natural history of cervical cancer, differences in risk for different cohorts, and the possible effects of other factors. It is likely that incidence rates will continue to change, and it will be necessary to monitor these and the screening programme with some care in order to make the best use of the resources available for cervical cytology.
and other authors have drawn attention to the rising numbers of deaths from cervical cancer among younger women during the 1970s in England and Wales. We have recently commented on trends in both mortality and incidence (Draper & Cook, 1982) .
There have also been reports from several other countries of an upward trend in the incidence of, and mortality from, cancer of the cervix among younger women. In Canada, in spite of extensive screening programmes, there has been a recent increase in the incidence of cancer of the cervix among women aged 20-34 in at least two provinces (Report of a Task Force..., 1982) . Increases in the incidence of invasive cancer of the cervix have been reported from two Australian states: in New South Wales the incidence of cervical cancer reported to the Central Cancer Registry during 1972-76 increased among women aged 20-39 in the years 1975 and 1976 (Armstrong & Holman, 1981) ; similarly in Queensland there was an increase in incidence of invasive cervical cancer, excluding microinvasive or Stage lA cancers, among women aged 20-44 between 1974 and 1980 (Bourne & Grove, 1983 . These trends in incidence correspond to the upward trend in mortality among younger women in Australia reported by Armstrong and Holman who showed that, although mortality from cervical cancer had tended to fall progressively since 1950, the rate for women aged less than 40 increased from about 1970. In New Zealand, Green (1979) reported a rise in mortality among women Correspondence: G.J. Draper. Received 25 January 1984; accepted 6 June 1984. aged 20-34, the rates having approximately doubled in the period [1959] [1960] [1961] [1962] [1963] [1964] [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] Thus, for the present analysis, we feel justified in ignoring these possible sources of error and assuming that any trends observed do in fact reflect true changes in mortality. It is of course also possible that changes in mortality reflect changes in survival rather than changes in incidence. Survival rates for 1971 to 1975 published by OPCS (1982) suggest that within each 10 year age group there were only small changes in survival rates between 1971 and 1975 . Data for earlier and later years appear not to be available for individual age groups and therefore we cannot entirely dismiss the possibility that there have been decreases in survival rates which could explain some of the increase in mortality. Evidence that the changes in mortality rates described below (Tables Ia and lb and Figure  1 ) are not solely due to changes in survival is provided by data on registration rates (Tables Ila  and Ilb) which show the same general pattern. Table Ia gives mortality rates for 3-year periods and 10-year age groups in England and Wales for the period 1950-82. Mortality rates for 5-year agegroups in successive years during the same period are shown in Figure 1 . There are considerable variations in the rates for individual age groups during this period. At ages 25-34, and possibly 15-24, there was a fall after the mid-1950s followed by a steep rise starting around 1970 which has continued until the present. At ages 35-44 the rate rose, fell, and is now rising again. At ages 45-54 small changes during the first 20 years of the period have been followed by a sharp decline since 1970. The most striking recent change in mortality is the increase at ages 25-34 where the rate has more than doubled -though the total number of deaths in this group is still on average only about 110 per year.
Corresponding mortality rates for Scotland are given in Table lb . The population of Scotland and 30-34 25-29 1950 1954 1958 1962 1966 1970 1974 1978 1982 Year of death Figure 1 Age specific death rates for cervical cancer in Wales 1950-1982. that the pattern at ages 40-44 tends to follow that for the age group 35-39 after an interval of around 5 years and similarly that the pattern of decline at ages 45-49 is followed about 5 years later by a corresponding decline in the age group 50-54 and then after another interval of about five years a decline for the age group 55-59.
These are examples of the well known phenomenon, originally pointed out by Hill & Adelstein (1967) Cohort effects in cervical cancer mortality rates have been discussed by Barrett (1973) and Osmond et al. ( ,1983 . The latter have fitted equations to the set of mortality rates for five-year age-groups during the period the number of cases registered; published registration data for later years have also been revised. There may of course be late registrations for any year but provided the proportion of such late registrations is small and the number unregistered is reasonably constant from year to year this will not influence the trends. Changes in the completeness of registration are unlikely to produce artefactual trends which only affect particular age groups. We believe that the observed trends represent real increases or decreases particularly since deaths and registrations show the same pattern. Each year a minority of uterine cancers are registered as 'unspecified'. This number has trebled from 156 in 1966 to 464 in 1980. These cases occur mostly among women in age groups above age 45 years. As with the "unspecified" deaths, it is unlikely that all these tumours ought to have been classified as "cervix uteri". But even if all of them are added to the registrations from invasive cervical cancer the numbers are not great enough to influence the observed trends, particularly in the younger age groups.
For Scotland registration data are available for the period 1959-80 separately for invasive cervical cancer and carcinoma in situ.
In Tables Ila and lIb respectively rates per million women for each 10-year age group, aggregated in 3-year periods.
In England and Wales there was a considerable increase in registrations at ages below 35 years during the years 1963-80, the rate having increased 4-fold at ages 15-24 (though there are still fewer than 50 cases a year in this age group) and by a factor of 21 at ages 25-34. Some of this increase may be ascribed to early diagnosis of microinvasive and some invasive cases discovered as a direct result of screening; thus to some extent the rates depend on the level of screening and they are not in fact true incidence rates. However, while this could be the complete explanation of the increase in the early years of the screening programme it seems unlikely to be so in more recent years. At ages 35-44 there have been substantial decreases in the rates, though that for ages 35-39 started to increase in 1975 and that for ages 40-44 four years later. At ages 45-54 an initial rise has been followed by a fall to about half of the peak rate.
In Scotland the pattern of change is very similar to that for England and Wales. However there is considerable year to year fluctuation in rates because of the small numbers involved. most obviously, the rates are to a considerable extent a reflection of the numbers of smears taken: in general as the number of smears taken increases the number of 'positive' cases will increase and, since registrations are expressed as rates relative to the total population rather than to the numbers who have been screened, this will appear as an increase in rates. Secondly, it seems fairly certain that not all cases of carcinoma in situ are in fact notified to cancer registries. However it is possible to draw one, admittedly tentative, conclusion from Table Illa . In Wales, between 1972-74 and 1978-80 , the number of smears notified to the D.H.S.S. increased by only about 19% -from about 2.31 million to about 2.75 million per year. It is estimated that in 1978-80 more than 60% were examinations for women who had had previous smears (unpublished data provided by D.H.S.S.). In general it is to be expected that the 'positive' rate will decrease with repeated screenings since an initially existing pool of positive cases (sometimes called the 'prevalence cases') will be depleted Scotland.
The high rates shown in Tables Illa and ITlb for  the period 1966-68, particularly Relationship between numbers of cervical smears and registrations of carcinoma in situ In Tables IVa and IVb we present the numbers of registrations of carcinoma in situ related to estimated numbers of smears taken in each year for various age groups. The numbers of registrations used for these tables are taken from published cancer registration data as explained above. The estimated numbers of smears for England and Wales are based on the summary forms SBH140 submitted to the D.H.S.S. by Area Health Authorities and cervical smear forms sent to the National Health Service Central Register (Roberts, 1982) ; similar arrangements exist for the Scottish data. Table IVa shows that in England and Wales rates of carcinoma in situ per thousand smears taken have been increasing, the sharpest increase occurring among women aged 25-29 and 30-34. In these two age groups the total number of smears The evidence from mortality rates presented above has been commented on by several previous authors (e.g. Beral, 1974; Yule, 1978; Draper & Cook, 1983 (Wright et al., 1978) , the possible direct effects of the contraceptive pill (Vessey et al., 1983) The reductions could conceivably also be partly explained by the increasing prevalence of hysterectomy performed for reasons other than cervical cancer. The effect of such an increase is effectively to decrease the population at risk, since the appropriate denominator for cervical cancer rates is the number of cervices rather than the number of women. The proportion of women having had a hysterectomy by any given age can be estimated using data from the Hospital Inpatient Enquiry (HIPE), which is based on hospital discharges in England and Wales, as described by Alderson & Donnan (1978 Macgregor & Teper (1978) showed that the mortality rates from cervical cancer for women aged [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] Draper (1982) and Burslem (1983) , explicitly acknowledge that the incidence among younger women may be increasing. However it should be emphasised that the level of screening among younger women should not be unreasonably increased at the expense of neglecting older women. In particular we would emphasise yet again that it is important that any woman over 35 who has not been screened should have at least one smear.
There are still doubts about the most effective strategy for screening and, particularly in view of current trends in incidence, very careful monitoring of the screening effort and the rates of both preclinical and clinical disease will be required. A prerequisite for such monitoring is the development of well-designed computerised information systems which will make it possible to record and analyse the necessary data.
